SMITH ASSET MANAGEMENT GROUP LP - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 168 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2017. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.

Quarter-by-quarter ownership
SMITH ASSET MANAGEMENT GROUP LP ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q2 2021$7,000
-12.5%
700.0%0.00%
Q1 2021$8,000
-97.0%
70
-96.4%
0.00%
-100.0%
Q4 2020$271,000
+68.3%
1,9600.0%0.02%
+100.0%
Q3 2020$161,000
+4.5%
1,960
-0.5%
0.01%0.0%
Q2 2020$154,000
+73.0%
1,970
-1.5%
0.01%
+60.0%
Q1 2020$89,000
+4.7%
2,0000.0%0.01%
+25.0%
Q4 2019$85,000
-1.2%
2,0000.0%0.00%
+33.3%
Q3 2019$86,000
-19.6%
2,000
+19.0%
0.00%
-25.0%
Q2 2019$107,000
+12.6%
1,680
+22.6%
0.00%
+33.3%
Q1 2019$95,000
-63.5%
1,370
-77.1%
0.00%
-66.7%
Q4 2018$260,000
-43.8%
5,970
-1.6%
0.01%
-30.8%
Q3 2018$463,000
+29.7%
6,070
+30.5%
0.01%
+30.0%
Q2 2018$357,000
+50.6%
4,6500.0%0.01%
+25.0%
Q1 2018$237,000
-40.3%
4,650
-45.6%
0.01%
-33.3%
Q4 2017$397,000
-12.7%
8,5500.0%0.01%
-20.0%
Q3 2017$455,000
-14.3%
8,5500.0%0.02%
-6.2%
Q2 2017$531,000
-9.4%
8,550
-1.2%
0.02%
-5.9%
Q1 2017$586,000
-3.8%
8,650
-0.1%
0.02%
-5.6%
Q4 2016$609,000
-1.9%
8,660
-1.1%
0.02%0.0%
Q3 2016$621,000
+45.1%
8,7600.0%0.02%
+38.5%
Q2 2016$428,000
-28.7%
8,760
-7.5%
0.01%
-27.8%
Q1 2016$600,000
-29.9%
9,470
+24.1%
0.02%
-28.0%
Q4 2015$856,0007,6300.02%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q1 2017
NameSharesValueWeighting ↓
First Light Asset Management, LLC 213,887$29,608,0002.19%
Rock Springs Capital Management LP 566,500$78,421,0001.66%
FEDERATED HERMES, INC. 4,280,528$592,554,0001.21%
AtonRa Partners 17,646$2,443,0001.20%
EMERALD MUTUAL FUND ADVISERS TRUST 218,390$30,232,0001.05%
EMERALD ADVISERS, LLC 226,875$31,406,0001.04%
Atika Capital Management LLC 89,000$12,319,0000.96%
Capital Impact Advisors, LLC 25,582$3,541,0000.87%
JGP Global Gestao de Recursos Ltda. 1,586$220,0000.83%
CAPITAL INTERNATIONAL LTD /CA/ 79,742$11,039,0000.64%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders